Site Search

... that they are generally larger, more complex molecules. Biologics are usually administered via injection or infusion. Most biologics in cancer care are given under the close supervision of a medical professional.   Q. What is a biosimilar? Answer: A biosimilar is a biologic product ... strength as its reference product.  Q. Why does the biosimilar pathway exist? Answer: Biologics have become an increasingly important part of health care. With the increasing attention to the costs of drugs, it became apparent that there was a need to create competition and choice that ... Your healthcare provider may have various reasons for selecting a branded biologic or biosimilar, including experience with the product, your health plan’s formulary (permitted drugs), patient preference, cost consciousness, or some combination of these factors. You should ask your ...

... nursing officer for the North Florida Regional Medical Center after serving for 21 years in this role. Scarlott had management and quality of care responsibilities for the areas of nursing, pharmacy, rehab, respiratory, regulatory and emergency services. She oversaw the first and ongoing ... to the Board of Directors American Cancer Society Cancer Action Network, Inc. in January 2016. Scarlott received a master's degree in public health from the University of North Carolina at Chapel Hill in 1985 and a bachelor of science in nursing degree from the University of North ...

... about advocating for cancer patients and their families. In 2017, I wrote a Letter to the Editor opposing the repeal of the Affordable Care Act and how important healthcare coverage is for cancer patients and the millions in this country without quality, affordable healthcare. My ... for Life. We know you are involved in the ACS CAN Black Volunteer Caucus. Can you tell us about this group and how it is helping ACS CAN promote health equity? I was honored to be nominated by my Grassroots Manager, Marc Mazza, and accepted on the National Black Volunteer Caucus. The BVC promotes health equity in ACS CAN in several ways. We provide Diversity, Equity, and Inclusion training for management and staff on being more aware of the ...

... are working together to make sure more Vermont residents can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, ... that have been excluded, including communities of color, individuals with lower socioeconomic status, rural communities, and those receiving care in non-academic medical centers are less likely to receive biomarker testing. Improving coverage for and access to biomarker testing across insurance types is key to reducing health disparities. Without action to expand coverage and access to biomarker testing, advances in precision medicine could increase existing ...